Published in Environ Health Perspect on March 01, 2000
What is an epigenetic transgenerational phenotype? F3 or F2. Reprod Toxicol (2007) 1.79
Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord (2007) 1.75
Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases. Reprod Toxicol (2007) 1.13
Regulation of the metastasis suppressor gene MKK4 in ovarian cancer. Gynecol Oncol (2007) 0.98
Prenatal arsenic exposure and drowning among children in Bangladesh. Glob Health Action (2015) 0.76
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet (1998) 13.27
Role for DNA methylation in genomic imprinting. Nature (1993) 12.65
Cancer epigenetics comes of age. Nat Genet (1999) 12.63
Histone acetylation and transcriptional regulatory mechanisms. Genes Dev (1998) 10.16
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet (1999) 9.53
Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet (1998) 7.52
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35
Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature (1981) 6.23
Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature (1995) 6.18
UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet (1997) 5.97
Genomic imprinting in mammalian development: a parental tug-of-war. Trends Genet (1991) 5.95
Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem (1992) 5.64
A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature (1990) 5.47
Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol (1988) 5.24
Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell (1993) 5.22
Parental imprinting of the mouse H19 gene. Nature (1991) 5.13
Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature (1997) 5.08
The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res (1999) 4.74
De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet (1997) 4.65
Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell (1984) 4.44
The DNA methylation paradox. Trends Genet (1999) 4.40
Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nat Genet (1996) 4.36
Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature (1984) 4.22
Genomic imprinting in mammals. Annu Rev Genet (1997) 4.21
Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet (1994) 4.04
Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet (1997) 3.95
Relaxation of imprinted genes in human cancer. Nature (1993) 3.86
Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet (1995) 3.79
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol (1999) 3.50
Gametic imprinting in mammals. Science (1995) 3.49
The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature (1991) 3.48
Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev (1993) 3.42
Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat Genet (1998) 3.38
Genomic imprinting--defusing the ovarian time bomb. Trends Genet (1994) 3.38
A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. Proc Natl Acad Sci U S A (1999) 3.37
Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet (1997) 3.32
Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature (1997) 3.27
Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature (1993) 3.24
Genomic imprinting is disrupted in interspecific Peromyscus hybrids. Nat Genet (1998) 3.22
Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature (1997) 3.20
Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature (1993) 3.11
Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet (1993) 3.08
Regulation of maternal behavior and offspring growth by paternally expressed Peg3. Science (1999) 3.07
Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat Genet (1997) 3.01
DNA methylation represses transcription in vivo. Nat Genet (1999) 2.92
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med (1998) 2.91
Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat Genet (1994) 2.90
Imprinting in Prader-Willi and Angelman syndromes. Trends Genet (1998) 2.85
Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell (1991) 2.80
Parental legacy determines methylation and expression of an autosomal transgene: a molecular mechanism for parental imprinting. Cell (1987) 2.78
The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat Genet (1997) 2.77
Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet (1996) 2.77
The Controlling Element in Sex Chromosome Behavior in Sciara. Genetics (1960) 2.75
The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet (1996) 2.63
Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2. Proc Natl Acad Sci U S A (1997) 2.52
DNA methylation and genomic imprinting. Cell (1994) 2.51
Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc Natl Acad Sci U S A (1996) 2.48
Differential imprinting and expression of maternal and paternal genomes. Annu Rev Genet (1988) 2.44
Imprinting mechanisms. Genome Res (1998) 2.37
Mosaic and polymorphic imprinting of the WT1 gene in humans. Nat Genet (1994) 2.35
Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain. Hum Mol Genet (1995) 2.27
Genomic imprinting: implications for human disease. Am J Pathol (1999) 2.26
Androgenetic origin of hydatidiform mole. Nature (1977) 2.24
Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet (1995) 2.24
Beyond the nucleosome: epigenetic aspects of position-effect variegation in Drosophila. Cell (1998) 2.24
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids. Hum Mol Genet (1999) 2.16
Creation of genomic methylation patterns. Nat Genet (1996) 2.15
A catalogue of imprinted genes and parent-of-origin effects in humans and animals. Hum Mol Genet (1998) 2.15
Allele-specific replication timing of imprinted gene regions. Nature (1993) 2.08
Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein. Nat Genet (1996) 2.06
An imprinted, mammalian bicistronic transcript encodes two independent proteins. Proc Natl Acad Sci U S A (1999) 2.05
Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature (1994) 2.03
Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum Mol Genet (1994) 1.97
Monoallelic expression of the human H19 gene. Nat Genet (1992) 1.96
Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet (1999) 1.93
Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat Genet (1997) 1.92
The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat Genet (1993) 1.84
Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes. Am J Hum Genet (1994) 1.79
Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem Biophys Res Commun (1993) 1.79
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet (1995) 1.77
Parental origin effects in mice. J Embryol Exp Morphol (1986) 1.77
Minimal definition of the imprinting center and fixation of chromosome 15q11-q13 epigenotype by imprinting mutations. Proc Natl Acad Sci U S A (1996) 1.76
Parental imprinting and human disease. Annu Rev Genet (1996) 1.72
Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues. Proc Natl Acad Sci U S A (1985) 1.68
Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat Genet (1995) 1.67
Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method. Nat Genet (1994) 1.66
Enhancer competition between H19 and Igf2 does not mediate their imprinting. Proc Natl Acad Sci U S A (1999) 1.64
Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem (1994) 1.63
Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet (1995) 1.60
Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum Mol Genet (1996) 1.57
Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome. Hum Mol Genet (1997) 1.54
Modification of 15q11-q13 DNA methylation imprints in unique Angelman and Prader-Willi patients. Hum Mol Genet (1993) 1.49
Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature (1994) 1.49
Influence of oxygen radical injury on DNA methylation. Mutat Res (1997) 1.43
Chromosomal basis of X chromosome inactivation: identification of a multigene domain in Xp11.21-p11.22 that escapes X inactivation. Proc Natl Acad Sci U S A (1998) 1.43
Chromosome imprinting and the mammalian X chromosome. Nature (1975) 1.40
Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. J Biol Chem (1996) 1.40
Partial isodisomy for maternal chromosome 7 and short stature in an individual with a mutation at the COL1A2 locus. Am J Hum Genet (1992) 1.40
Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys (1995) 3.20
Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res (2000) 2.73
The measured electrical properties of normal and malignant human tissues from 50 to 900 MHz. Med Phys (1994) 2.32
Genomic imprinting: implications for human disease. Am J Pathol (1999) 2.26
Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res (1982) 1.81
M6P/IGF2R imprinting evolution in mammals. Mol Cell (2000) 1.77
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet (1995) 1.77
Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys (1998) 1.65
Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med (1993) 1.45
Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg (1995) 1.40
Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology (1995) 1.38
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys (2001) 1.38
Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum Mol Genet (2001) 1.32
M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene (1996) 1.31
Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A (1997) 1.29
Monotreme IGF2 expression and ancestral origin of genomic imprinting. J Exp Zool (2001) 1.28
Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res (1990) 1.27
The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2. Genomics (2001) 1.24
Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer (1999) 1.23
Transplantation system for determining the clonogenic survival of parenchymal hepatocytes exposed to ionizing radiation. Cancer Res (1981) 1.22
Imprinted genes in liver carcinogenesis. FASEB J (1997) 1.22
Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene (1995) 1.22
Bacterial infection promotes DNA hypermethylation. J Dent Res (2007) 1.22
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Int J Radiat Oncol Biol Phys (2001) 1.21
Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys (1997) 1.20
Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys (1994) 1.19
Theoretical and measured electric field distributions within an annular phased array: consideration of source antennas. IEEE Trans Biomed Eng (1993) 1.17
Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer (1993) 1.16
Epigenetic detection of human chromosome 14 uniparental disomy. Hum Mutat (2003) 1.15
M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene (2000) 1.14
Isolation, culture, and transplantation of human hepatocytes. J Natl Cancer Inst (1982) 1.12
Marsupials and Eutherians reunited: genetic evidence for the Theria hypothesis of mammalian evolution. Mamm Genome (2001) 1.09
Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond) (2013) 1.05
Plasma transforming growth factor-beta 1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. Lung Cancer (1996) 1.04
Morphologic and histochemical analysis of hepatocytes transplanted into syngeneic hosts. Am J Pathol (1980) 1.03
Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology (1994) 1.02
Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations. J Biol Chem (1999) 1.01
The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer (1998) 1.01
Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol (2001) 1.00
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg (1995) 1.00
Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats. Cancer Res (1982) 0.99
Imprinted M6p/Igf2 receptor is mutated in rat liver tumors. Oncogene (1998) 0.99
Microwave power absorption differences between normal and malignant tissue. Int J Radiat Oncol Biol Phys (1980) 0.98
Imprint status of M6P/IGF2R and IGF2 in chickens. Dev Genes Evol (2001) 0.98
Repair of radiation damage in noncycling parenchymal hepatocytes. Br J Radiol (1982) 0.96
Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine. Cancer Res (1984) 0.96
Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res (1995) 0.96
Establishment of two rat hepatoma cell strains produced by a carcinogen initiation, phenobarbital promotion protocol. In Vitro (1983) 0.93
Effects of partial hepatectomy on transplanted hepatocytes. Cancer Res (1982) 0.93
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers. Cancer Res (1999) 0.92
Effects of EGF and calcium on adult parenchymal hepatocyte proliferation. J Cell Physiol (1987) 0.90
Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators. Cancer Res (1984) 0.90
Imprinting of PEG3, the human homologue of a mouse gene involved in nurturing behavior. Genomics (2001) 0.90
Exclusion of maternal uniparental disomy of chromosome 14 in patients referred for Prader-Willi syndrome using a multiplex methylation polymerase chain reaction assay. J Med Genet (2003) 0.88
Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations. Hum Mutat (2001) 0.86
Short communication: normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGF beta. Br J Radiol (1995) 0.86
Polymorphisms, genomic imprinting and cancer susceptibility. Mutat Res (1999) 0.86
Human hepatocyte-mediated mutagenesis and DNA repair activity. Carcinogenesis (1983) 0.86
The influence of in situ repair systems on survival of several irradiated parenchymal cell types. Br J Cancer Suppl (1984) 0.85
Down-regulation of transforming growth factor beta receptor type I, II, and III during liver regeneration. Am J Surg (1995) 0.84
The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene. Oncogene (1997) 0.84
Intracolonic WR 2721 protection of the rat colon from acute radiation injury. Gastroenterology (1986) 0.84
Radiation sensitivity of adult human parenchymal hepatocytes. Radiat Res (1988) 0.81
Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer. Prostate Cancer Prostatic Dis (2006) 0.81
An in vitro micronucleus assay for determining the radiosensitivity of hepatocytes. Radiat Res (1989) 0.80
Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity. Bone Marrow Transplant (1995) 0.80
Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. Prog Clin Biol Res (1991) 0.80
BSA treatment of plasticware reduces TGF beta binding. Biotechniques (1994) 0.80
Blood flow to lymphatic metastases in conscious rats. Eur J Cancer (1981) 0.80
Cross-species clues of an epigenetic imprinting regulatory code for the IGF2R gene. Cytogenet Genome Res (2006) 0.80
The survival of parenchymal hepatocytes irradiated with low and high LET radiation. Br J Cancer Suppl (1984) 0.80
Genomic structure of the human M6P/IGF2 receptor. Mamm Genome (1999) 0.80
Transforming growth factor-beta receptors type I, II and III in phenobarbital-promoted rat liver tumors. Carcinogenesis (1994) 0.80
Induction of sister chromatid exchanges in cultured adult rat hepatocytes by directly and indirectly acting mutagens/carcinogens. Carcinogenesis (1987) 0.79
Survival of parenchymal hepatocytes irradiated with 14.3 MeV neutrons. Int J Radiat Oncol Biol Phys (1984) 0.78
Effect of 5-hydroxytryptamine on tissue blood flow and microwave heating of rat tumors. Cancer Res (1985) 0.78
Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome. Transl Psychiatry (2012) 0.78
Promoting effect of nicotinamide on the development of renal tubular cell tumors in rats initiated with diethylnitrosamine. Cancer Res (1985) 0.78
Microwave hyperthermia and its effect on tumor blood flow in rats. Cancer Res (1983) 0.78
Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology (1995) 0.78
Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation. Carcinogenesis (1988) 0.78
Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels. Carcinogenesis (1996) 0.77
Ability of partial hepatectomy to induce gamma-glutamyltranspeptidase in regenerated and transplanted hepatocytes of Fischer 344 and Wistar-Furth rats. Cancer Res (1985) 0.77
Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen. Clin Cancer Res (1997) 0.77
Genotoxic effects of 2-acetylaminofluorene on rat and human hepatocytes. Environ Health Perspect (1983) 0.77
Radiosensitivity of parenchymal hepatocytes as a function of oxygen concentration. Radiat Res (1989) 0.77
Independent mechanisms for tumor promoters phenobarbital and 12-O-tetradecanoylphorbol-13-acetate in reduction of epidermal growth factor binding by rat hepatocytes. Cancer Res (1989) 0.77
Uptake and clearance of plutonium-238 from liver cells transplanted into fat pads of F344 rats. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 0.77
Phenobarbital decreases hepatocyte EGF receptor expression independent of protein kinase C activation. Biochem Biophys Res Commun (1989) 0.76
EGF receptors of hepatocytes from rats treated with phenobarbital are sensitized to down-regulation by phenobarbital in culture. Toxicol Appl Pharmacol (2000) 0.76
Schizophrenia, cancer and imprinting: early nutritional influences. Br J Psychiatry (2006) 0.76
Reversible and phorbol ester-specific defect of protein kinase C translocation in hepatocytes isolated from phenobarbital-treated rats. Cancer Res (1991) 0.76
Cell proliferation and regulation of negative growth factors in mouse liver foci. Carcinogenesis (1996) 0.75
Induction of sister chromatid exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator, Wy-14,643. Mutat Res (1993) 0.75
Transforming growth factor-beta plasma concentrations in patients with leukemia and lymphoma receiving chemoradiotherapy and marrow transplantation. Blood (1994) 0.75
The effects of a purified diet on sister chromatid exchange frequencies and mitotic activity in adult rat hepatocytes. Carcinogenesis (1991) 0.75
The occurrence of polymorphism of mannose 6-phosphate/insulin-like growth factor 2 receptor gene in laboratory and wild rats. J UOEH (1999) 0.75
Erythrokinetics in mice bearing tumours in either preirradiated or unirradiated tissue. Cell Tissue Kinet (1978) 0.75
Aquatic genotoxicity testing with rat hepatocytes in primary culture. I. SCE induction. Sci Total Environ (1993) 0.75